¼¼°èÀÇ ¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå º¸°í¼­(2025³â)
Latex Agglutination Test Kits Global Market Report 2025
»óǰÄÚµå : 1705251
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,344,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,170,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,996,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â ¿¬Æò±Õ 7.0%ÀÇ CAGR·Î 20¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº °¨¿°¼º ¹× ÀÚ°¡¸é¿ªÁúȯÀÇ À¯º´·ü Áõ°¡, ½Å¼Ó ¹× ÇöÀåÁø´Ü(POC) ±â¼ú äÅà Áõ°¡, ÇöÀåÁø´Ü(Point-of-Care) äÅà Áõ°¡, ¼ºº´¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, È£Èí±â °¨¿°ÁõÀÇ À¯º´·ü Áõ°¡ µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, Å×½ºÆ® ½ºÆ®¸³ ±â¼ú, Ç׿ø °Ë»ç, ÀÚµ¿È­ ±â¼ú, ÇöÀå °Ë»ç µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

°¨¿°º´ À¯ÇàÀÇ ±ÞÁõÀº ´çºÐ°£ ¶óÅØ½º ÀÀÁý °Ë»ç ŰƮ ½ÃÀåÀÇ È®ÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼±Õ, ¹ÙÀÌ·¯½º, °õÆÎÀÌ, ±â»ýÃæ, ÇÁ¸®¿Â µî º´¿ø¼º ¹Ì»ý¹°¿¡ ÀÇÇÑ °¨¿°Àº ¼¼°èÈ­, Ç×±ÕÁ¦ ³»¼º, µµ½ÃÈ­, ±âÈĺ¯È­, Àα¸ Áõ°¡ µîÀ¸·Î ÀÎÇØ Áõ°¡ Ãß¼¼¿¡ ÀÖ½À´Ï´Ù. ¶óÅØ½º ÀÀÁý °Ë»ç´Â ¼¼±Õ ¹× ¹ÙÀÌ·¯½º °¨¿°À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ °¨¿°ÁõÀÇ ½Å¼ÓÇÑ °ËÃâ¹ýÀ¸·Î Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, UNAIDSÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2022³â Àü ¼¼°è HIV °¨¿°ÀÚ ¼ö´Â 3,900¸¸ ¸íÀ¸·Î 2020³â ´ëºñ 3.17% Áõ°¡ÇÏ¿© ¾à 130¸¸ ¸íÀÇ ½Å±Ô HIV °¨¿°ÀÌ º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ´Â 2022³â ¹Ì±¹¿¡¼­ 8,331¸íÀÇ °áÇ٠ȯÀÚ°¡ ¹ß»ýÇß´Ù°í º¸°íÇßÀ¸¸ç, ÀÌ´Â Àü³â ´ëºñ 5.9% Áõ°¡ÇÑ ¼öÄ¡ÀÔ´Ï´Ù. µû¶ó¼­ °¨¿°º´ È®»êÀÇ È®´ë´Â ¶óÅØ½º ÀÀÁý °Ë»ç ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶óÅØ½º ÀÀÁý Å×½ºÆ® ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ½ÄÁßµ¶ ¹× ȯ°æ ¿À¿° ¹°Áú Áø´Ü ±â¼ú µµÀÔ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ºü¸£°í »ç¿ëÇϱ⠽¬¿î ¶óÅØ½º ÀÀÁý ÃøÁ¤¹ýÀ» Á¦°øÇÔÀ¸·Î½á Áúº´ Áø´ÜÀ» °­È­ÇÏ°í °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®Àº º´¿øÃ¼ °ËÃâÀ» °£¼ÒÈ­ÇÏ¿© ½Äǰ ¹× ȯ°æ ½Ã·á¿¡¼­ º´¿øÃ¼¸¦ ºü¸£°í ½±°Ô ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Gold Standard Diagnostics LLC´Â 2024³â 3¿ù Microgen Rapid Latex Agglutination Assay¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ °Ë»ç´Â ½Äǰ ¹× ȯ°æ »ùÇÿ¡¼­ »ì¸ð³Ú¶ó±Õ, ·¹Áö¿À³Ú¶ó±Õ, Ȳ»öÆ÷µµ»ó±¸±ÕÀÇ ±ºÁý°ú °°Àº ƯÁ¤ º´¿ø±ÕÀÇ Áø´ÜÀ» È®ÀÎÇϱâ À§ÇØ °í¾ÈµÈ °ÍÀ¸·Î, ½Å¼ÓÇÏ°í °£ÆíÇÏ¸ç ºñ¿ë È¿À²ÀûÀÎ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ±âÁ¸ ¹è¾ç¹ýÀ» ´ëüÇÒ ¼ö ÀÖ´Â ¹Î°¨ÇÏ°í Æ¯ÀÌÀûÀÎ ¹æ¹ýÀ¸·Î, ´Ü 2ºÐ ¸¸¿¡ ¿Ï·áµÇ¸ç ½ÇÇè½Ç ¿öÅ©Ç÷ο쿡 ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ü¼ø¼ºÀ¸·Î ÀÎÇØ ½ÇÇè½ÇÀº Àü¹®ÀûÀÎ ±³À°À̳ª Àåºñ ¾øÀ̵µ Áï½Ã »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Latex agglutination test kits serve as vital diagnostic tools in clinical settings, facilitating the identification of specific antigens or antibodies in biological materials. Operating on the principle of antigen-antibody interactions, these kits offer rapid and precise detection of various infectious diseases, thereby aiding in timely treatment and containment efforts. Due to their versatility and reliability, they are extensively utilized in laboratories.

The main product types of latex agglutination test kits include enzyme-linked immunosorbent assay, indirect fluorescent, hemagglutination inhibition, and serum neutralization. Enzyme-linked immunosorbent assay (ELISA) is a type of test wherein enzymes aid in detecting antibodies or antigens in a sample. Widely employed in laboratories for diagnosing diseases or monitoring health conditions such as infectious diseases or allergies, ELISA encompasses antibody detection and antigen testing. These tests are conducted on sample types such as blood, urine, cerebrospinal fluid, and others, and are applied across various settings including hospitals, diagnostic centers, and specialty clinics.

The latex agglutination test kits market research report is one of a series of new reports from The Business Research Company that provides latex agglutination test kits market statistics, including latex agglutination test kits industry global market size, regional shares, competitors with a latex agglutination test kits market share, detailed latex agglutination test kits market segments, market trends and opportunities, and any further data you may need to thrive in the latex agglutination test kits industry. This latex agglutination test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The latex agglutination test kits market size has grown strongly in recent years. It will grow from $1.49 billion in 2024 to $1.6 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growth in the prevalence of infectious diseases, increasing funding for research and development in diagnostics, increasing focus on infection control measures in healthcare facilities, and increasing adoption of latex agglutination tests in water quality testing.

The latex agglutination test kits market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the rising prevalence of infectious and autoimmune diseases, the rising adoption of rapid and POC technology, the increasing adoption of point-of-care diagnostics, growing awareness about sexually transmitted infections, and the and the rising incidence of respiratory tract infections. Major trends in the forecast period include technological advancements, test strip technology, antigen tests, automated technologies, and point-of-care testing.

The surge in infectious diseases prevalence is anticipated to propel the expansion of the latex agglutination test kit market in the foreseeable future. Infectious diseases, stemming from pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions, are on the rise due to globalization, antimicrobial resistance, urbanization, climate change, and population growth. Latex agglutination tests serve as a rapid detection method for various infectious diseases, including bacterial and viral infections. For example, data from UNAIDS indicates a global HIV population of 39 million in 2022, marking a 3.17% increase from 2020, with approximately 1.3 million new HIV infections reported. Additionally, the Centers for Disease Control and Prevention reported 8,331 tuberculosis cases in the United States in 2022, representing a 5.9% rise from the previous year. Hence, the escalating prevalence of infectious diseases is poised to fuel the latex agglutination test kit market's growth.

Leading companies in the latex agglutination test kits market are concentrating on introducing diagnostic technologies for foodborne illnesses and environmental contaminants. They aim to enhance disease diagnosis and gain a competitive advantage by offering rapid and user-friendly latex agglutination assays. These assays streamline pathogen detection, providing quick and straightforward identification in food and environmental samples. For instance, Gold Standard Diagnostics LLC launched Microgen rapid latex agglutination tests in March 2024. These tests, designed for confirming the diagnosis of specific pathogens such as Salmonella, Legionella, or Staphylococcus aureus colonies in food and environmental samples, offer rapid, easy, and cost-effective techniques. They serve as highly sensitive and specific alternatives to conventional culture procedures, completing within as little as two minutes and seamlessly integrating into laboratory workflows. Their simplicity allows labs to utilize them immediately without requiring specialized training or equipment.

In January 2023, Gold Standard Diagnostics LLC acquired Microgen Bioproducts Ltd., a UK-based biotechnology company specializing in diagnostic test kits and instruments, including latex agglutination tests for identifying bacteria. This acquisition aims to broaden Gold Standard Diagnostics LLC's portfolio of diagnostic test kits and instruments.

Major companies operating in the latex agglutination test kits market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Hardy Diagnostics, Meridian Bioscience Inc., BioLegend Inc., ELITechGroup, Fujirebio, Sekisui Diagnostics LLC, R-Biopharm AG, Savyon Diagnostics Ltd., Creative Diagnostics, ZeptoMetrix Corporation, HiMedia Laboratories, DIALAB GmbH, Arlington Scientific Inc., Biotium Inc., Atlas Medical GmbH, Pro Lab Diagnostics Inc., Gold Standard Diagnostics Industrial Solutions

North America was the largest region in the latex agglutination test kits market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex agglutination test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the latex agglutination test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The latex agglutination test kits market consists of sales of microbial identification kits, serological test kits, and blood typing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Latex Agglutination Test Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on latex agglutination test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for latex agglutination test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The latex agglutination test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

1) By Enzyme-Linked Immunosorbent Assay (Elisa) - Sandwich Elisa; Competitive Elisa; Indirect Elisa

2) By Indirect Fluorescent - Direct Immunofluorescence Assay (Difa); Indirect Immunofluorescence Assay (Ifa)

3) By Hemagglutination Inhibition - Virus-Specific Hemagglutination Inhibition Tests

4) By Serum Neutralization - Virus Neutralization Assays; Cytopathic Effect Neutralization Assays

Table of Contents

1. Executive Summary

2. Latex Agglutination Test Kits Market Characteristics

3. Latex Agglutination Test Kits Market Trends And Strategies

4. Latex Agglutination Test Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Latex Agglutination Test Kits Growth Analysis And Strategic Analysis Framework

6. Latex Agglutination Test Kits Market Segmentation

7. Latex Agglutination Test Kits Market Regional And Country Analysis

8. Asia-Pacific Latex Agglutination Test Kits Market

9. China Latex Agglutination Test Kits Market

10. India Latex Agglutination Test Kits Market

11. Japan Latex Agglutination Test Kits Market

12. Australia Latex Agglutination Test Kits Market

13. Indonesia Latex Agglutination Test Kits Market

14. South Korea Latex Agglutination Test Kits Market

15. Western Europe Latex Agglutination Test Kits Market

16. UK Latex Agglutination Test Kits Market

17. Germany Latex Agglutination Test Kits Market

18. France Latex Agglutination Test Kits Market

19. Italy Latex Agglutination Test Kits Market

20. Spain Latex Agglutination Test Kits Market

21. Eastern Europe Latex Agglutination Test Kits Market

22. Russia Latex Agglutination Test Kits Market

23. North America Latex Agglutination Test Kits Market

24. USA Latex Agglutination Test Kits Market

25. Canada Latex Agglutination Test Kits Market

26. South America Latex Agglutination Test Kits Market

27. Brazil Latex Agglutination Test Kits Market

28. Middle East Latex Agglutination Test Kits Market

29. Africa Latex Agglutination Test Kits Market

30. Latex Agglutination Test Kits Market Competitive Landscape And Company Profiles

31. Latex Agglutination Test Kits Market Other Major And Innovative Companies

32. Global Latex Agglutination Test Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Latex Agglutination Test Kits Market

34. Recent Developments In The Latex Agglutination Test Kits Market

35. Latex Agglutination Test Kits Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â